Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Ketamine and other potential glutamate antidepressants.

Dutta A, McKie S, Deakin JF.

Psychiatry Res. 2015 Jan 30;225(1-2):1-13. doi: 10.1016/j.psychres.2014.10.028. Epub 2014 Nov 13.

PMID:
25467702
2.

Resting state networks in major depressive disorder.

Dutta A, McKie S, Deakin JF.

Psychiatry Res. 2014 Dec 30;224(3):139-51. doi: 10.1016/j.pscychresns.2014.10.003. Epub 2014 Oct 13.

PMID:
25456520
3.

Mapping glucose-mediated gut-to-brain signalling pathways in humans.

Little TJ, McKie S, Jones RB, D'Amato M, Smith C, Kiss O, Thompson DG, McLaughlin JT.

Neuroimage. 2014 Aug 1;96:1-11. doi: 10.1016/j.neuroimage.2014.03.059. Epub 2014 Mar 28.

4.

TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.

McFarquhar M, Elliott R, McKie S, Thomas E, Downey D, Mekli K, Toth ZG, Anderson IM, Deakin JF, Juhasz G.

Neuropsychopharmacology. 2014 Jun;39(7):1743-53. doi: 10.1038/npp.2014.22. Epub 2014 Jan 29.

PMID:
24549102
6.

Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.

Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R, McDonald K.

J Neuropsychol. 2013 Sep;7(2):306-25. doi: 10.1111/jnp.12026. Epub 2013 Jul 31.

PMID:
23901888
7.

State-dependent changes in hippocampal grey matter in depression.

Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, Downey D, Williams S, Deakin JF, Anderson IM.

Mol Psychiatry. 2013 Dec;18(12):1265-72. doi: 10.1038/mp.2012.150. Epub 2012 Nov 6.

PMID:
23128153
8.

Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment.

Arnone D, McKie S, Elliott R, Thomas EJ, Downey D, Juhasz G, Williams SR, Deakin JF, Anderson IM.

Am J Psychiatry. 2012 Aug;169(8):841-50. doi: 10.1176/appi.ajp.2012.11121774.

PMID:
22854930
9.

Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

Hodkinson DJ, de Groote C, McKie S, Deakin JF, Williams SR.

Br J Med Med Res. 2012 Sep;2(3):373-385.

10.

Reversed frontotemporal connectivity during emotional face processing in remitted depression.

Goulden N, McKie S, Thomas EJ, Downey D, Juhasz G, Williams SR, Rowe JB, Deakin JF, Anderson IM, Elliott R.

Biol Psychiatry. 2012 Oct 1;72(7):604-11. doi: 10.1016/j.biopsych.2012.04.031. Epub 2012 Jun 6.

11.

Sample size estimation for comparing parameters using dynamic causal modeling.

Goulden N, Elliott R, Suckling J, Williams SR, Deakin JF, McKie S.

Brain Connect. 2012;2(2):80-90. doi: 10.1089/brain.2011.0057. Epub 2012 Jun 11.

PMID:
22559836
12.

Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI.

Symonds CS, McKie S, Elliott R, William Deakin JF, Anderson IM.

Eur Neuropsychopharmacol. 2012 Dec;22(12):867-74. doi: 10.1016/j.euroneuro.2012.03.008. Epub 2012 Apr 20.

PMID:
22521875
13.

Functional neuroimaging demonstrates that ghrelin inhibits the central nervous system response to ingested lipid.

Jones RB, McKie S, Astbury N, Little TJ, Tivey S, Lassman DJ, McLaughlin J, Luckman S, Williams SR, Dockray GJ, Thompson DG.

Gut. 2012 Nov;61(11):1543-51. Epub 2012 Feb 7.

PMID:
22315469
14.

A temporal analysis of the central neural processing of itch.

Kleyn CE, McKie S, Ross A, Elliott R, Griffiths CE.

Br J Dermatol. 2012 May;166(5):994-1001. doi: 10.1111/j.1365-2133.2012.10849.x.

PMID:
22283926
15.

Effects of patellar taping on brain activity during knee joint proprioception tests using functional magnetic resonance imaging.

Callaghan MJ, McKie S, Richardson P, Oldham JA.

Phys Ther. 2012 Jun;92(6):821-30. doi: 10.2522/ptj.20110209. Epub 2012 Jan 26.

16.

Reduced medial prefrontal responses to social interaction images in remitted depression.

Elliott R, Lythe K, Lee R, McKie S, Juhasz G, Thomas EJ, Downey D, Deakin JF, Anderson IM.

Arch Gen Psychiatry. 2012 Jan;69(1):37-45. doi: 10.1001/archgenpsychiatry.2011.139.

PMID:
22213787
17.

Assessment of the impact of the scanner-related factors on brain morphometry analysis with Brainvisa.

Shokouhi M, Barnes A, Suckling J, Moorhead TW, Brennan D, Job D, Lymer K, Dazzan P, Reis Marques T, Mackay C, McKie S, Williams SC, Lawrie SM, Deakin B, Williams SR, Condon B.

BMC Med Imaging. 2011 Dec 21;11:23. doi: 10.1186/1471-2342-11-23.

18.

Fatty acid-induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humans.

Van Oudenhove L, McKie S, Lassman D, Uddin B, Paine P, Coen S, Gregory L, Tack J, Aziz Q.

J Clin Invest. 2011 Aug;121(8):3094-9. doi: 10.1172/JCI46380. Epub 2011 Jul 25.

19.

Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: a pharmacological-challenge fMRI (phMRI) study.

McKie S, Richardson P, Elliott R, Völlm BA, Dolan MC, Williams SR, Anderson IM, Deakin JF.

Neuroimage. 2011 Sep 15;58(2):497-507. doi: 10.1016/j.neuroimage.2011.06.049. Epub 2011 Jun 25.

PMID:
21726650
20.

The Neuro/PsyGRID calibration experiment: identifying sources of variance and bias in multicenter MRI studies.

Suckling J, Barnes A, Job D, Brennan D, Lymer K, Dazzan P, Marques TR, MacKay C, McKie S, Williams SR, Williams SC, Deakin B, Lawrie S.

Hum Brain Mapp. 2012 Feb;33(2):373-86. doi: 10.1002/hbm.21210. Epub 2011 Mar 21.

PMID:
21425392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk